Publication details
Hypolipidemika a cílové hodnoty lipidů
| Title in English | Hypolipidemic treatment and target values of lipids |
|---|---|
| Authors | |
| Year of publication | 2018 |
| Type | Article in Periodical |
| Magazine / Source | Interní medicína pro praxi |
| MU Faculty or unit | |
| Citation | |
| Keywords | dyslipidemia; cardiovascular diseases; LDL cholesterol; triglycerides; statins; PCSK9 inhibitors |
| Description | Hypolipidemics are one of the most frequently prescribed drugs in the world. Last year, the updated guidelines were released:European Guidelines on cardiovascular disease prevention in clinical practice by European Society of Cardiology (ESC) and ESC/EAS (European Atherosclerosis Society) Guidelines for the Management of Dyslipidaemias. Both of them contain changes mainlyin estimation of individual cardiovascular risk and target levels of LDL-cholesterol. Targeting these goals is usually very difficultand often impossible in patients with familial hypercholesterolemia. PCSK9 inhibitors are a new and very potent hypolipidemicsthat should make target LDL-cholesterol levels reachable. |